SEI Investments
XERS icon

SEI Investments’s Xeris Biopharma Holdings XERS Stock Holding History

SEI Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.36M Buy
579,210
+179,863
+45% +$1.19M ﹤0.01% 1757
2025
Q4 		$3.13M Buy
399,347
+278,171
+230% +$2.19M ﹤0.01% 1629
2025
Q3 		$986K Buy
121,176
+4,642
+4% +$30.8K ﹤0.01% 1968
2025
Q2 		$544K Buy
116,534
+19,043
+20% +$87.3K ﹤0.01% 2149
2025
Q1 		$535K Buy
+97,491
New +$394K ﹤0.01% 2127

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SEI Investments's XERS Position: Q1 2026 in Review

SEI Investments increased its Xeris Biopharma Holdings (XERS) stake by 45% in Q1 2026, buying an estimated $1.19M and bringing the position to 579,210 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

SEI Investments first reported a position in XERS in Q1 2025 and has held it in 5 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • SEI Investments held 579,210 shares of Xeris Biopharma Holdings worth $3.36M as of Q1 2026.
  • SEI Investments bought 179,863 Xeris Biopharma Holdings shares in Q1 2026, an estimated $1.19M.
  • Xeris Biopharma Holdings made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #1757 holding.
  • SEI Investments first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 5 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.